Company profile
MIMEDX GROUP, INC.
NASDAQ:MDXGMedical/Dental Instruments
Clinical trials (6)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02844660 | — | completed | 2016-07-01 | 2018-07-01 | MiMedx Group, Inc. | Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers |
| NCT03414255 | phase3 | completed | 2018-01-09 | 2021-03-30 | MiMedx Group, Inc. | Micronized dHACM Injectable for the Treatment of Achille Tendonitis |
| NCT02427191 | phase2_3 | completed | 2015-03-31 | 2018-08-01 | MiMedx Group, Inc. | Micronized dHACM Injectable for the Treatment of Plantar Fasciitis |
| NCT03414268 | phase3 | completed | 2018-01-08 | 2021-03-17 | MiMedx Group, Inc. | Micronized dHACM Injectable for the Treatment of Plantar Fasciitis |
| NCT03485157 | phase2 | completed | 2018-03-27 | 2022-04-19 | MiMedx Group, Inc. | Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee |
FDA applications (0)
No records yet.